Stock market week-in-review for 5 large GI companies — Aug. 21-25

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Aug. 21 to Aug. 25.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $223.92 on Aug. 21
Peaked: $225.60 on Aug. 24
Closed: $222.31 on Aug. 25
Percent change between Aug. 21 to Aug. 25: -0.71 percent

2. Exact Sciences Corp.

Opened: $37.90 on Aug. 21
Peaked: $41.16 on Aug. 24
Closed: $39.96 on Aug. 25
Percent change between Aug. 21 to Aug. 25: 5.43 percent

3. Johnson & Johnson

Opened: $132.29 on Aug. 21
Peaked: $134.73 on Aug. 22
Closed: $131.73 on Aug. 25
Percent change between Aug. 21 to Aug. 25: -0.42 percent

4. Synergy Pharmaceuticals

Opened: $2.91 on Aug. 21
Peaked: $3.11 on Aug. 25
Closed: $3.09 on Aug. 25
Percent change between Aug. 21 to Aug. 25: 6.18 percent

5. Valeant Pharmaceuticals

Opened: $14.34 on Aug. 21
Peaked: $15.05 on Aug. 24
Closed: $14.12 on Aug. 25
Percent change between Aug. 21 to Aug. 25: -1.53 percent

More articles on gastroenterology:
Florida jury finds gastroenterologist not liable in alleged ‘slapdash colonoscopy’ trial — 6 insights
Contaminated scopes used in 500+ patients at Buffalo VA
Renewed interest in gastroparesis research brings cure into focus 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.